List of Apotex patents

Patents where

Current Assignee

Name

Apotex

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11377456 Crystalline form of Remdesivir	Patent 11377456 was granted and assigned to Apotex on July, 2022 by the United States Patent and Trademark Office.	Apotex	Apotex	United States Patent and Trademark Office	11377456	July 5, 2022
‌ US Patent 8703156 Liquid formulation for deferiprone with palatable taste	Patent 8703156 was granted and assigned to Apotex on April, 2014 by the United States Patent and Trademark Office.		Apotex	United States Patent and Trademark Office	8703156	April 22, 2014
‌ US Patent 9376419 Solid forms of nilotinib hydrochloride	Patent 9376419 was granted and assigned to Apotex on June, 2016 by the United States Patent and Trademark Office.	Apotex	Apotex	United States Patent and Trademark Office	9376419	June 28, 2016
‌ US Patent 11345706 Crystalline forms of Acalabrutinib	Patent 11345706 was granted and assigned to Apotex on May, 2022 by the United States Patent and Trademark Office.	Apotex	Apotex	United States Patent and Trademark Office	11345706	May 31, 2022
‌ US Patent 7049328 Use for deferiprone	Patent 7049328 was granted and assigned to Apotex on May, 2006 by the United States Patent and Trademark Office.		Apotex	United States Patent and Trademark Office	7049328	May 23, 2006
‌ US Patent 10016423 Solid forms of nilotinib hydrochloride	Patent 10016423 was granted and assigned to Apotex on July, 2018 by the United States Patent and Trademark Office.	Apotex	Apotex	United States Patent and Trademark Office	10016423	July 10, 2018
‌ US Patent 11440871 Zuclomiphene salts and crystalline forms thereof		Apotex	Apotex	United States Patent and Trademark Office	11440871	September 13, 2022
‌ US Patent 10407396 Crystalline form of selexipag	Patent 10407396 was granted and assigned to Apotex on September, 2019 by the United States Patent and Trademark Office.	Apotex	Apotex	United States Patent and Trademark Office	10407396	September 10, 2019
‌ US Patent 9944616 Processes for the preparation of Tasimelteon and intermediates thereof	Patent 9944616 was granted and assigned to Apotex on April, 2018 by the United States Patent and Trademark Office.	Apotex	Apotex	United States Patent and Trademark Office	9944616	April 17, 2018
‌ US Patent 9809551 Solid forms of Ivacaftor and processes for the preparation thereof	Patent 9809551 was granted and assigned to Apotex on November, 2017 by the United States Patent and Trademark Office.	Apotex	Apotex	United States Patent and Trademark Office	9809551	November 7, 2017
‌ US Patent 10513504 Processes for the preparation of apalutamide and intermediates thereof	Patent 10513504 was granted and assigned to Apotex on December, 2019 by the United States Patent and Trademark Office.	Apotex	Apotex	United States Patent and Trademark Office	10513504	December 24, 2019
‌ US Patent 11220500 Crystalline form of Valbenazine dibesylate	Patent 11220500 was granted and assigned to Apotex on January, 2022 by the United States Patent and Trademark Office.	Apotex	Apotex	United States Patent and Trademark Office	11220500	January 11, 2022
‌ US Patent 11072620 Crystalline forms of Ponatinib hydrochloride	Patent 11072620 was granted and assigned to Apotex on July, 2021 by the United States Patent and Trademark Office.	Apotex	Apotex	United States Patent and Trademark Office	11072620	July 27, 2021
‌ US Patent 7893269 Process for the manufacture of 3-hydroxy-N-alkyl-1-cycloalky1-6-alkyl-4-oxo-1,4-dihydropyridine-2-carboxamide and its related analogues	Patent 7893269 was granted and assigned to Apotex on February, 2011 by the United States Patent and Trademark Office.		Apotex	United States Patent and Trademark Office	7893269	February 22, 2011
‌ US Patent 9260438 Solid forms of tofacitinib salts	Patent 9260438 was granted and assigned to Apotex on February, 2016 by the United States Patent and Trademark Office.	Apotex	Apotex	United States Patent and Trademark Office	9260438	February 16, 2016
‌ US Patent 10301322 Processes for the preparation of edoxaban and intermediates thereof	Patent 10301322 was granted and assigned to Apotex on May, 2019 by the United States Patent and Trademark Office.	Apotex	Apotex	United States Patent and Trademark Office	10301322	May 28, 2019
‌ US Patent 9382233 Forms of vilazodone and processes for the preparation thereof	Patent 9382233 was granted and assigned to Apotex on July, 2016 by the United States Patent and Trademark Office.	Apotex	Apotex	United States Patent and Trademark Office	9382233	July 5, 2016
‌ US Patent 8735602 Pharmaceutically acceptable salts of thymodepressin and processes for their manufacture	Patent 8735602 was granted and assigned to Apotex on May, 2014 by the United States Patent and Trademark Office.		Apotex	United States Patent and Trademark Office	8735602	May 27, 2014
‌ US Patent 8119606 Crystalline D-isoglutamyl-D-tryptophan and the mono ammonium salt of D-isoglutamyl-D-tryptophan	Patent 8119606 was granted and assigned to Apotex on February, 2012 by the United States Patent and Trademark Office.		Apotex	United States Patent and Trademark Office	8119606	February 21, 2012
‌ US Patent 8207217 Crystalline forms of the mono-sodium salt of D-isoglutamyl-D-tryptophan	Patent 8207217 was granted and assigned to Apotex on June, 2012 by the United States Patent and Trademark Office.		Apotex	United States Patent and Trademark Office	8207217	June 26, 2012
‌ US Patent 8481588 Crystalline forms of the mono-sodium salt of D-isoglutamyl-D-tryptophan	Patent 8481588 was granted and assigned to Apotex on July, 2013 by the United States Patent and Trademark Office.		Apotex	United States Patent and Trademark Office	8481588	July 9, 2013
‌ US Patent 11236066 Crystalline forms of niraparib tosylate	Patent 11236066 was granted and assigned to Apotex on February, 2022 by the United States Patent and Trademark Office.	Apotex	Apotex	United States Patent and Trademark Office	11236066	February 1, 2022
‌ US Patent 8673943 Fluorinated derivatives of deferiprone	Patent 8673943 was granted and assigned to Apotex on March, 2014 by the United States Patent and Trademark Office.		Apotex	United States Patent and Trademark Office	8673943	March 18, 2014
‌ US Patent 10183024 Crystalline forms of ibrutinib	Patent 10183024 was granted and assigned to Apotex on January, 2019 by the United States Patent and Trademark Office.	Apotex	Apotex	United States Patent and Trademark Office	10183024	January 22, 2019
‌ US Patent 8026261 Fluorinated derivatives of deferiprone	Patent 8026261 was granted and assigned to Apotex on September, 2011 by the United States Patent and Trademark Office.		Apotex	United States Patent and Trademark Office	8026261	September 27, 2011

Results per page:

54 results

0 selected

54 results

0 selected